Background Antibodies against phospholipase A 2 receptor 1 (PLA 2 R1) are found in 80%
of patients with membranous nephropathy, and previous studies described three …

Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …

Membranous nephropathy (MN) is the most prevalent cause of nephrotic syndrome amongst
the non-diabetic adult population. A fifth of idiopathic nephrotic syndrome cases can be …

The discovery of circulating antibodies specific for native podocyte antigens has transformed
the diagnostic workup and greatly improved management of idiopathic membranous …

Research on autoimmune processes involved in glomerulonephritis has been for years
based on experimental models. Recent progress in proteomics has radically modified …

Previous studies that have assessed the association of pre‐transplant antiphospholipase A2
receptor autoantibody (PLA 2R‐Ab) concentration with a recurrence of membranous …

The pathogenesis of membranous nephropathy: evolution and re... : Current Opinion in
Nephrology and Hypertension The pathogenesis of membranous nephropathy: evolution and …

Background Membranous nephropathy (MN) can recur in kidney allografts leading to graft
dysfunction and failure. The aims of these analyses were to assess MN recurrence, clinical …

Background: Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful in diagnosing
idiopathic membranous nephropathy (IMN). We investigated the clinical relevance of PLA2R …

The deposition of antipodocyte autoantibodies in the glomerular subepithelial space
induces primary membranous nephropathy (MN), the leading cause of nephrotic syndrome …